Clinical Trials Logo

Clinical Trial Summary

With a completely bedside blood culture diagnostics system (BACTEC blood culture system in combination with the Accelerate ID/AST System) it is possible to optimize the initial antimicrobial therapy in patients with sepsis and septic shock.

Prospective observational, open-label mono-center study to compare a completely bedside blood culture diagnostics system (BACTEC blood culture system in combination with the Accelerate ID/AST System and Curetis Univero System) with standard blood culture diagnostics in patients with sepsis or septic shock.


Clinical Trial Description

n/a


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT03000049
Study type Observational
Source University Medicine Greifswald
Contact Matthias Gründling, MD
Email gruendli@uni-greifswald.de
Status Recruiting
Phase N/A
Start date November 2016
Completion date September 2017